Pedestrians walk by the Pfizer corporate headquarters in New York City on Thursday, December 3, 2020. Pfizer Inc. expects to ship only half of the COVID-19 vaccines it originally planned for this year due to supply-chain problems. Photo by John Angelillo/UPI